Dr. Victor Mulanovich, MD

• Infectious Disease Medicine

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Peruvian University Cayetano Heredia / Academic Program Of Medicine

  Medical School, 1990

• Delay of Alternative Antiviral Therapy and Poor Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Recipients of Allogeneic Stem Cell Transplant, 2018-03-13

• The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score, 2021-11-01

• ActiveMycobacterium tuberculosisinfection at a comprehensive cancer center, 2006-2014, 2019-11-06

• 22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome, 2021-12-04

• 1410. Isoniazid Therapy for Latent Tuberculosis Infection in Patients with Cancer Treated with Checkpoint Inhibitors Immunotherapy, 2021-12-04

• Clinical presentation and outcomes of non-typhoidalSalmonellainfections in patients with cancer, 2021-09-29